INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 429s ago
HOUSE PTR13m ago
SEC 13F13m ago
ROBINHOOD CHAIN13m ago
Corporate insider
BS

Benzeno Sharon

Chief Commercial Ofc Imm MedCIK 0001780854

EDGAR filingsOpen in network
Disclosed transactions19
Buys / sells0 / 3
Max Insider Score28
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
0
BS
Benzeno SharonChief Commercial Ofc Imm Med
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$134K
11.0K sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Adaptive Biotechnologies CorpChief Commercial Ofc Imm Med · Dec 8, 2025
14
BS
Benzeno SharonChief Commercial Ofc Imm Med
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL
$232K
11.0K sh
Jun 26, 2026
Jun 30, 2026
traded Jun 26, 2026
+4d
SEC FORM 4

Evidence

0
BS
Benzeno SharonChief Commercial Ofc Imm Med
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$22K
1,837 sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC FORM 4

Evidence

2
BS
Benzeno SharonChief Commercial Ofc Imm Med
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$211K
24.9K sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC FORM 4

Evidence

2
BS
Benzeno SharonChief Commercial Ofc Imm Med
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$100K
24.9K sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC FORM 4

Evidence

5
BS
Benzeno SharonChief Commercial Ofc Imm Med
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$419K
51.6K sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC FORM 4

Evidence

28
BS
Benzeno SharonChief Commercial Ofc Imm Med
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$3.27M
154.8K sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC FORM 4

Evidence

0
BS
Benzeno SharonChief Commercial Ofc Imm Med
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
11.0K sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC FORM 4

Evidence

0
BS
Benzeno SharonChief Commercial Ofc Imm Med
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
1,837 sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC FORM 4

Evidence

7
BS
Benzeno SharonChief Commercial Ofc Imm Med
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
24.9K sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC FORM 4

Evidence

3
BS
Benzeno SharonChief Commercial Ofc Imm Med
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
24.9K sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC FORM 4

Evidence

7
BS
Benzeno SharonChief Commercial Ofc Imm Med
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
51.6K sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC FORM 4

Evidence

2
BS
Benzeno SharonChief Commercial Ofc Imm Med
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$52K
4,290 sh
Dec 4, 2025Dec 8, 2025
traded Dec 4, 2025
+4dSEC FORM 4

Evidence

0
BS
Benzeno SharonChief Commercial Ofc Imm Med
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$35K
4,157 sh
Dec 4, 2025Dec 8, 2025
traded Dec 4, 2025
+4dSEC FORM 4

Evidence

0
BS
Benzeno SharonChief Commercial Ofc Imm Med
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$17K
4,157 sh
Dec 4, 2025Dec 8, 2025
traded Dec 4, 2025
+4dSEC FORM 4

Evidence

23
BS
Benzeno SharonChief Commercial Ofc Imm Med
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$212K
12.6K sh
Dec 4, 2025Dec 8, 2025
traded Dec 4, 2025
+4dSEC FORM 4

Evidence

7
BS
Benzeno SharonChief Commercial Ofc Imm Med
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
4,290 sh
Dec 4, 2025Dec 8, 2025
traded Dec 4, 2025
+4dSEC FORM 4

Evidence

3
BS
Benzeno SharonChief Commercial Ofc Imm Med
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
4,157 sh
Dec 4, 2025Dec 8, 2025
traded Dec 4, 2025
+4dSEC FORM 4

Evidence

0
BS
Benzeno SharonChief Commercial Ofc Imm Med
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
4,157 sh
Dec 4, 2025Dec 8, 2025
traded Dec 4, 2025
+4dSEC FORM 4

Evidence